China Interventional Cardiovascular Device Industry Report, 2011-2012
  • Aug./2012
  • Hard Copy
  • USD $1,900
  • Pages:80
  • Single User License
    (PDF Unprintable)       
  • USD $1,800
  • Code: XJT017
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $2,800
  • Hard Copy + Single User License
  • USD $2,100
As the increase in the morbidity of cardiovascular and cerebrovascular diseases, the rise in per capita income and the expansion of medical insurance payment proportion, the demand for interventional cardiovascular devices has been effectively released in China in recent years. In 2011, the interventional cardiovascular device market scale (by the selling price of hospital terminals) in China approximated RMB11.69 billion, of which, the market size of cardiovascular stents hit RMB8.17 billion and that of the supporting devices for operation approximated RMB3.52 billion. In 2007-2011, the cardiovascular stent market scale of China presented a CAGR of 21.0%.

China Cardiovascular Stent Market Scale and Growth Rate, 2007-2011

In recent years, Chinese interventional cardiovascular device enterprises have made much progress in R&D capability, scale of capital and brand influence, seizing more and more market share thanks to their advantages in price and channel. And the foreign counterparts are going into overdrive to tap into Chinese market by establishing plants there or by joint venture and M&A. At present, Chinese industrial players far outstrip its foreign peers concerning the market occupancy of coronary stents, while the foreign businesses still dominate the supporting device market.? ?

Having laid a sound foundation and formed a competitive pattern, the interventional cardiovascular device industry of China characterizes quite high entry barriers. Thus, disorderly competition will pose little risk to the businesses, ensuring their gross margin at a higher level. In 2007-2011, the gross margins of leading players in interventional cardiovascular device industry including MicroPort, Lepu Medical and weigaogroup were all kept above 75.0%.? ?

The report highlights the followings :
20120114.gif Market scale, import & export, profit level, competition pattern, etc of Chinese interventional cardiovascular device industry;
20120114.gif Regulatory policy, industrial policy, entry barrier, influence from upstream and downstream sectors;
20120114.gif Market segments such as coronary stent, balloon catheter, conduit, etc.
20120114.gif Production, operation, business, operation in China of Top 5 foreign interventional cardiovascular device manufacturers;
20120114.gif Production, operation, investment, M&A and businesses of leading Chinese interventional cardiovascular device manufacturers.
1. Overview of Interventional Cardiovascular Device Industry
1.1 Definition
1.2 Product Category and Application
1.3 Industry Chain

2. Status Quo of Interventional Cardiovascular Device Industry in China
2.1 General Situation
2.2 Market Demand
2.3 Import & Export
2.4 Competitive Landscape
2.5 Profit
2.6 Entry Barriers
2.6.1 Technical Process
2.6.2 Talents
2.6.3 Patents
2.6.4 Policies
2.6.5 Marketing Channel

3. Development Environment of China Interventional Cardiovascular Device Industry
3.1 Policy Environment
3.1.1 Regulatory Policies
3.1.2 Industry Policies
3.2 Upstream and Downstream Sectors
3.2.1 Upstream
3.2.2 Downstream

4. Market Segments of China Interventional Cardiovascular Device Industry
4.1 Coronary Stent
4.1.1 Market Overview
4.1.2 Drug-eluting Stent
4.1.3 Bare Metal Stent
4.1.4 Bioabsorbable Stent
4.2 Balloon Catheter
4.2.1 Market Overview
4.2.2 Supply & Demand
4.3 Catheter
4.3.1 Market Overview
4.3.2 Sale
4.4 Guidewire
4.4.1 Market Overview
4.4.2 Sale
4.5 Sheath Introducer Kit and Auxiliary Device
4.5.1 Market Overview
4.5.2 Sale

5. Foreign Production Enterprises
5.1 Johnson & Johnson
5.1.1 Profile
5.1.2 Operation
5.1.3 Interventional Cardiovascular Device Business
5.1.4 Operation in China
5.2 Medtronic
5.2.1 Profile
5.2.2 Operation
5.2.3 Operation in China
5.3 Boston Scientific
5.3.1 Profile
5.3.2 Operation
5.3.3 Operation in China
5.4 Abbott Laboratories
5.4.1 Profile
5.4.2 Operation
5.4.3 Operation in China
5.5 B. Braun
5.5.1 Profile
5.5.2 Operation
5.5.3 Operation in China

6. Chinese Production Enterprises
6.1 MicroPort
6.1.1 Profile
6.1.2 Operation
6.1.3 Revenue Structure
6.1.4 Gross Margin
6.1.5 R&D and Investment
6.1.6 Interventional Cardiovascular Device Business
6.1.7 Forecast and Outlook
6.2 Lepu Medical
6.2.1 Profile
6.2.2 Operation
6.2.3 Revenue Structure
6.2.4 Gross Margin
6.2.5 R&D and Investment
6.2.6 Interventional Cardiovascular Device Business
6.2.7 Forecast and Outlook
6.3 JWMS
6.3.1 Profile
6.3.2 Operation
6.3.3 Development
6.4 LBC
6.4.1 Profile
6.4.2 Operation
6.4.3 Development
6.5 OrbusNeich (Shenzhen)
6.5.1 Profile
6.5.2 Operation
6.5.3 Development
6.6 Fuji Suntech
6.6.1 Profile
6.6.2 Operation
6.6.3 Development
6.7 SCW
6.7.1 Profile
6.7.2 Operation
6.7.3 Development
Types and Functions of Interventional Cardiovascular Devices
Types and Characteristics of Cardiovascular Stents
China Interventional Cardiovascular Device Industry Chain
Revenue and Growth Rate of China Medical Device Industry, 2006-2011
Market Scale of Cardiovascular Stents Industry in China, 2007-2011
Number of PCI Operation Cases in China, 2002-2012
Coronary Stent Implantation Number in China, 2002-2012
Import of Major Interventional Medical Devices and Materials in China, 2008
Equipment Product Line Layout of MicroPort and Lepu, 2011
Gross Margin of Major Interventional Cardiovascular Device Manufacturers in China, 2007-2011
Operation Mode of Interventional Cardiovascular Device Industry in China
Policies of China Interventional Cardiovascular Device Industry, 2006-2011
Hierarchical Structure of Hospitals in China (by Level), 2006-Oct. 2011
Total Health Care Costs and % of GDP in China, 2000-2010
Population Aged 65 and % of Total Population in China, 1982-2010
Per Capita Disposable Income of Urban Residents and Per Capita Net Income of Rural Households in China, 2001-2011
Medical Insurance Coverage of the Crowd and the Level of Expenditure in China
Charges of Interventional Operations paid by Health Insurance in Beijing, Shanghai and Guangzhou, 2011
Coronary Stent Market Scale in China, 2007-2015
Drug-eluting Stents in China, 2010
The Ceiling Retail Price of Cardiac Stent Products in Shanghai, 2012
Cardiovascular Stents Tender Price of a Hospital in Shanghai, 2012
Some Bare Metal Stents in China, 2010
Demand for Coronary Artery Balloon Catheters in China, 2002-2011
Average Purchase Price of Balloon Catheters in China, 2010
Some Rapid Exchange Expansion Balloon Catheters in China, 2010
The Ceiling Retail Price of Balloon Catheter Products in Shanghai, 2012
Average Purchase Price of Catheters in China, 2010
Guide Catheters in China, 2010
The Ceiling Retail Price of Catheter Products in Shanghai, 2012
Average Purchase Price of Guidewires in China, 2010
Some Guidewires in China, 2010
Average Purchase Price of Sheath Introducer Kit and Auxiliary Devices in China, 2010
Revenue and Net Income of Johnson & Johnson, 2008-2011
Revenue Structure of Johnson & Johnson (by Product), 2011
Revenue of Cordis, 2007-2011
Companies in China and Major Products of Johnson & Johnson
Revenue and Total Profit of Johnson & Johnson Medical (China) Ltd., 2007-2008
Gross Margin of Johnson & Johnson Medical (China) Ltd., 2007-2008
Total Assets and Total Liabilities of Johnson & Johnson Medical (China) Ltd., 2007-2008
Revenue and Net Income of Medtronic, FY2008-FY2011
Revenue and Proportion of Cardiovascular Products of Medtronic, FY2008-FY2011
Revenue and Total Profit of Medtronic (Shanghai) Co., Ltd., 2007-2008
Gross Margin of Medtronic (Shanghai) Co., Ltd., 2007-2008
Total Assets and Total Liabilities of Medtronic (Shanghai) Co., Ltd., 2007-2008
Revenue and Net Income of Boston Scientific, 2008-2011
Revenue of Boston Scientific by Product, 2009-2011
Revenue and Net Income of Abbott, 2008-2011
Revenue and % of Total Revenue of Abbott Vascular Devices Department, 2008-2011
Revenue and Growth Rate of B. Braun Aesculap Surgical Instruments Department, 2006-2011
Revenue and Net Income of MicroPort, 2008-2011
Revenue of MicroPort by Product, 2008-2011
Revenue of MicroPort by Region, 2008-2011
Gross Margin of MicroPort, 2008-2011
R&D Costs and % of Total Revenue of MicroPort, 2008-2011
Competitive Edges of Cardiac Stents Field of MicroPort
Key Financial Indicators of Dongguan Kewei, 2010-2011
Revenue and Net Income of MicroPort, 2011-2013E
Revenue and Net Income of Lepu Medical, 2008-2011
Revenue of Lepu Medical by Product, 2008-2011
Revenue of Lepu Medical by Region, 2008-2011
Gross Margin of Lepu Medical, 2008-2011
R&D Costs and % of Total Revenue of Lepu Medical, 2008-2011
Revenue and Net Income of Lepu Medical, 2011-2013E
Revenue and Total Profit of JWMS, 2007-2009
Gross Margin of JWMS, 2007-2009
Total Assets and Total Liabilities of JWMS, 2007-2009
Revenue and Total Profit of LBC, 2008-2009
Gross Margin of LBC, 2008-2009
Total Assets and Total Liabilities of LBC, 2008-2009
Revenue and Total Profit of OrbusNeich (Shenzhen), 2007-2009
Gross Margin of OrbusNeich (Shenzhen), 2007-2009
Total Assets and Total Liabilities of OrbusNeich (Shenzhen), 2007-2009
Revenue and Total Profit of Fuji Suntech, 2008-2009
Gross Margin of Fuji Suntech, 2008-2009
Total Assets and Total Liabilities of Fuji Suntech, 2008-2009
Revenue and Total Profit of SCW, 2007-2009
Gross Margin of SCW, 2007-2009
Total Assets and Total Liabilities of SCW, 2007-2009
Export Delivery Value and % of Revenue of SCW, 2005-2009

China Blood Product Industry Report, 2020-2027

With the adjustment in the catalog of medicines covered by national medical insurance system, the scope and reimbursement ratio of almost all blood products for clinical use grow tremendously, which h...

China Medical Robot Industry Report, 2020-2026

Medical robot is the most promising segment of service robot market. By one estimate, globally 7,200 units of medical robots were sold and valued at $2.58 billion in 2019, compared with 5,100 units (u...

China In Vitro Diagnostic (IVD) Industry Report, 2019-2025

In vitro diagnosis (IVD) as a good way to make a rapid and definite diagnosis of diseases early, plays an increasingly crucial role in clinical medicine and related medical research fields. China’s IV...

China Aged Care Industry Report, 2019-2025

China’s society has aged before it gets rich. By the end of 2018, people aged over 60 had numbered 249.5 million in the country, or 17.9% of the total population, of which those aged over 65 were 167 ...

China Dental Industry Report, 2019-2025

Nowadays, the Chinese people have a growing awareness of oral health and healthy behaviors. 60.1% of residents have knowledge about oral health; 24.1% of 5-year-old children and 31.9% of 12-year-old c...

China Hospital Industry Report,2019-2025

The people’s growing awareness of health care and the acceleration of population aging have brought prosperity to China’s hospital industry. As of February 2019, there had been a total of 33,000 hospi...

China Dental Industry Report, 2017-2021

As living standards continue to improve and the awareness of oral health grows, consumers’ demand for dental services has kept increasing and the dental industry in China has witnessed robust developm...

China Interferon Industry Report, 2016-2021

Interferon is mainly used for the treatment of hepatitis B, hepatitis C, multiple sclerosis, condyloma acuminatum and other diseases. Wherein, IFN-α is mainly suitable for curing hepatitis B and hepat...

China Hospital Industry Report,2016-2020

In recent years, "Opinions on Promoting the Development of Health Service Industry" and other related policies, the people’s growing awareness of health care and the acceleration of population aging h...

China Aged Care Industry Report, 2016-2020

China entered the aging society early in 1999. By the end of 2015, China’s population aged over 60 reached 222 million and the old-age dependency ratio 13.9%. By 2020, China’s population aged over 60 ...

China Medical Robotics Industry Report, 2016-2020

Medical robotics can be used in surgery, rescue, transport, care, rehabilitation, dispensing and so on for the sick and wounded. Especially, surgical, rehabilitation and dispensing robots are the R &a...

China Dental Industry Report, 2016-2020

The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental apparatus (equipments and consumables), dental medical services, etc. With ...

China Medical Imaging Diagnosis Industry Report, 2015-2019

Against the background of a surge in social demand, handsome profit and the favorable opportunity brought by health care reform, the medical imaging industry, especially medical imaging equipment indu...

China Heparin Industry Report, 2015-2018

As the world's largest heparin API producer and exporter, China seizes about 80% share of the global heparin API market. After the explosive growth in 2008-2010, the stagnant international market and ...

Global and China Stem Cell Industry Report, 2015-2018

Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. Currently, stem cells are used to treat hund...

China Hospital Industry Report, 2015-2018

Stimulated by the demand, the number of hospitals in China rose from 21,979 in 2011 to 26,479 at the end of May 2015, an increase of 4,500 in total. Among them, public hospitals showed an overall decl...

China Independent Clinical Laboratory Industry Report, 2015-2018

The independent clinical laboratory originated from the U.S. and is relatively mature in developed countries/regions like North America, Europe, and Japan, whose independent clinical laboratory market...

China Medical Robot Industry Report, 2014-2018

Medical robots can be applied to surgeries, rescue, transport, nursing and rehabilitation of the sick and wounded. Wherein, surgery and rehabilitation robots are two striking market segments. Due to ...

2005- All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号